European Institute of Oncology
Milan, Italy
47 recruiting
Showing 1–20 of 47 trials
Recruiting
Phase 3
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Squamous Cell Carcinoma of Head and Neck
Janssen Research & Development, LLC500 enrolled137 locationsNCT07276399
Recruiting
A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting
Carcinoma, Non-Small Cell Lung
Janssen Research & Development, LLC380 enrolled45 locationsNCT07230691
Recruiting
Phase 2
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Endometrial Cancer
Canadian Cancer Trials Group393 enrolled100 locationsNCT05640999
Recruiting
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
FIGO Grade 1 Endometrial Endometrioid AdenocarcinomaFIGO Grade 2 Endometrial Endometrioid AdenocarcinomaStage IA1 Endometrial Cancer FIGO 2023+1 more
Mayo Clinic212 enrolled20 locationsNCT06689956
Recruiting
CompArative Analysis Between, Thymic, pulmonaRy and Pancreatic Well Differentiated High Grade Neuroendocrine Tumors
Neuroendocrine Carcinoma of LungNeuroendocrine Carcinoma of Thymus
European Institute of Oncology34 enrolled1 locationNCT07429851
Recruiting
Breast Cancer RElapsed in Patients Treated With Adjuvant CDK4/6 Inhibitors:
Adjuvant TherapyCDK4/6 Inhibitor
European Institute of Oncology750 enrolled18 locationsNCT07180693
Recruiting
Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement
Sentinel Lymph Node Biopsy (SLNB)ALNDTargeted Axillary Dissection (TAD)
European Institute of Oncology150 enrolled14 locationsNCT07278726
Recruiting
Phase 2
Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple Negative Breast Cancer Patients
European Institute of Oncology45 enrolled5 locationsNCT06690840
Recruiting
Not Applicable
fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases
Invasive Breast CancerHER2-positive Breast Cancer
European Institute of Oncology145 enrolled1 locationNCT06328465
Recruiting
Not Applicable
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC
Sentinel Lymph Node Biopsy (SLNB)Invasive Breast CarcinomaNeoadjuvant Chemotherapy
European Institute of Oncology75 enrolled1 locationNCT07080944
Recruiting
Percutaneous Cryoablation of Low-risk Early Breast Cancer
Breast Cancer
European Institute of Oncology234 enrolled1 locationNCT06300125
Recruiting
Emotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy
Metastatic Breast Cancer
European Institute of Oncology1,000 enrolled37 locationsNCT06994377
Recruiting
A New Tool to Promote Patient's Engagement in Their Healthcare Process
Breast CarcinomaBreast Cancer Stage IBreast Cancer Stage II
European Institute of Oncology180 enrolled1 locationNCT06762496
Recruiting
Phase 2Phase 3
INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC
Head and Neck Squamous Cell Carcinoma (HNSCC)
Inhibrx Biosciences, Inc410 enrolled88 locationsNCT06295731
Recruiting
Not Applicable
Multimodal Approach in Patients With mHSPC. Randomized Trial of APA+ADT vs APA-ADT and Local Treatment
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano566 enrolled3 locationsNCT05649943
Recruiting
Not Applicable
CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancEr
Prostate Cancer
European Institute of Oncology60 enrolled1 locationNCT06331013
Recruiting
Not Applicable
Impact of Augmented Reality During Robot-assisted Radical Prostatectomy
Prostatic Neoplasm
European Institute of Oncology318 enrolled1 locationNCT06059859
Recruiting
Personalization of External Beam Radiation Therapy in Localised Tumours
Breast AdenocarcinomaProstate Cancer (Adenocarcinoma)
European Institute of Oncology35 enrolled1 locationNCT07047495
Recruiting
Evaluation of the PreCursor-M+® in CIN2
Cervical Intraepithelial Neoplasia Grade 2
European Institute of Oncology100 enrolled2 locationsNCT06403618
Recruiting
Not Applicable
Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast Cancer
Breast Cancer Invasive
European Institute of Oncology92 enrolled1 locationNCT06790264